ChroMedX Accepts Proposal; Signs LOI with Diagnostic Marketing Experts to Conduct a Value-Based Transaction for the HemoPalm Blood Analyzer System Medical Device Investing
RepliCel CEO: Anticipating the Approval of Their Dermal Injector, its Impact in Europe and Beyond Medical Device Investing
ChroMedX appoints Ants Kahu & Associates to Implement Quality Management System Medical Device Investing
BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission Medical Device Investing